X
    學術可視化工作室RC   登錄   提交文稿
學術英文編修

IMMUNOLOGY AND CELL BIOLOGY

期刊標題檢索 IMMUNOL CELL BI 最新評論: Did it show "under review" immediately after you submitted it? (2024-07-06)


期刊名稱:   ISSN:   主題領域:   影響因子範圍: -
索引:   類別:   開放訪問:   排序方式:

[IMMUNOLOGY AND CELL BIOLOGY]您好,您是該頁面的第 31000 位訪客。

期刊簡介
期刊名稱IMMUNOLOGY AND CELL BIOLOGY IMMUNOLOGY AND CELL BIOLOGY
LetPub Score
7.4
50 ratings
Rate

Reputation
8.8

Influence
6.3

Speed
7.0

期刊簡稱IMMUNOL CELL BIOL
ISSN0818-9641
E-ISSN1440-1711
h-index96
CiteScore
CiteScoreSJRSNIPCiteScore Rank
7.501.1740.693
Subject fieldQuartilesRankPercentile
Category: Medicine
Subcategory: Immunology and Allergy
Q275 / 233
Category: Medicine
Subcategory: Immunology
Q290 / 236
Category: Medicine
Subcategory: Cell Biology
Q2115 / 285

自引率 (2023-2024)6.20%自引率趨勢
掲載範囲
The Australasian Society for Immunology Incorporated (ASI) was created by the amalgamation in 1991 of the Australian Society for Immunology, formed in 1970, and the New Zealand Society for Immunology, formed in 1975. The aim of the Society is to encourage and support the discipline of immunology in the Australasian region. It is a broadly based Society, embracing clinical and experimental, cellular and molecular immunology in humans and animals. The Society provides a network for the exchange of information and for collaboration within Australia, New Zealand and overseas. ASI members have been prominent in advancing biological and medical research worldwide. We seek to encourage the study of immunology in Australia and New Zealand and are active in introducing young scientists to the discipline.
官方網站http://www.nature.com/icb/index.html
在線稿件提交http://mts-icb.nature.com/cgi-bin/main.plex
開放訪問No
出版商John Wiley & Sons Inc.
主題領域医学
出版國/地區AUSTRALIA
發行頻率隔月刊行
創刊年0
每年文章數62每年文章數趨勢
黃金OA百分比43.53%
Web of Science 四分位
2023-2024
WOS Quartile: Q3

CategoryEditionJIF QuartileJIF RankingJIF Percentage
CELL BIOLOGYSCIEQ3123/205
IMMUNOLOGYSCIEQ399/181
索引 (SCI or SCIE)Science Citation Index
Science Citation Index Expanded
鏈接到PubMed Central (PMC)https://www.ncbi.nlm.nih.gov/nlmcatalog?term=0818-9641%5BISSN%5D
平均審稿時間 *來自出版商的數據:
來自作者的數據: Sort of slow, 4-8 Week(s)
競爭力 *來自作者的數據: Ordinary
參考鏈接
相關期刊 【IMMUNOLOGY AND CELL BIOLOGY】CiteScore趨勢
自引率趨勢 每年文章數趨勢
作者評論
*所有的審稿過程指標,如接受率和審稿速度,僅限於用戶提交的稿件。因此,這些指標可能無法準確反映期刊的競爭力或速度。
  • 同一學科的期刊
  • CiteScore趨勢
  • 自引率趨勢
  • 每年文章數趨勢
  •  
    學科內的可信期刊 影響因子
    NATURE REVIEWS IMMUNOLOGYH-index: 351

    CiteScore: 93.40
    NATURE IMMUNOLOGYH-index: 344

    CiteScore: 40.00
    Annual Review of ImmunologyH-index: 279

    CiteScore: 57.20
    ImmunityH-index: 355

    CiteScore: 49.40
    Cellular & Molecular ImmunologyH-index: 64

    CiteScore: 31.20
    TRENDS IN IMMUNOLOGYH-index: 209

    CiteScore: 25.10
    JOURNAL OF EXPERIMENTAL MEDICINEH-index: 411

    CiteScore: 26.60
    AUTOIMMUNITY REVIEWSH-index: 103

    CiteScore: 24.70
    BRAIN BEHAVIOR AND IMMUNITYH-index: 127

    CiteScore: 29.60
    JOURNAL OF AUTOIMMUNITYH-index: 101

    CiteScore: 27.90
    學科內最受檢索的期刊 頁面查看次數
    International Immunopharmacology337403
    JOURNAL OF IMMUNOLOGY156801
    Immunity108117
    Cellular & Molecular Immunology107572
    Vaccine104879
    JOURNAL OF EXPERIMENTAL MEDICINE99619
    MICROBIAL PATHOGENESIS94357
    MOLECULAR IMMUNOLOGY91239
    INFLAMMATION89894
    BRAIN BEHAVIOR AND IMMUNITY84922
  •  

    IMMUNOLOGY AND CELL BIOLOGY IMMUNOLOGY AND CELL BIOLOGY
    明年預測:
    穩步上升 無變化 逐步下降  刷新
  •  

     
  •  

     


首頁    上一頁    1    下一頁    末頁  (頁
/1)
  [IMMUNOLOGY AND CELL BIOLOGY] 的評論撰寫評論
作者: Max Gladstone


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-07-06 15:03:58 評論於
Did it show "under review" immediately after you submitted it?
(0) 讚! | Max Gladstone

作者: Max Gladstone


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-07-05 22:09:18 評論於
Hello, I would like to ask if IMMUNOL CELL BIOL will show "under review" immediately after submission.
(0) 讚! | Max Gladstone

作者: Max Gladstone


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-07-05 21:43:37 評論於
Hello, I would like to ask if IMMUNOL CELL BIOL will display "under review" immediately after submission.
(0) 讚! | Max Gladstone

作者: Max Gladstone


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-07-05 16:51:19 評論於
Hello, I would like to ask if IMMUNOL CELL BIOL will show "under review" immediately after submission.
(0) 讚! | Max Gladstone

作者: 无击鹏运


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-12-07 10:09:59 評論於
Please translate the following paragraph into English and Japanese, respectively, and title them as ":" and "
(0) 讚! | 无击鹏运

作者: 弹腿盼丹


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-11-02 15:45:25 評論於
Has your article been submitted? Is the review process fast?
(0) 讚! | 弹腿盼丹

作者: Marguerite Jordan


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-09-29 09:01:45 評論於
Why can't I open the submission link? Please provide the official website URL
(0) 讚! | Marguerite Jordan

作者: gren


領域: 医学
審稿時間: 2.0 month(s)
結果: 修改後接受


撰寫評論

2022-10-09 21:14:06 評論於
The reviewer is very responsible and has provided many constructive suggestions, which have improved the quality of the manuscript. The editor is also very diligent and responsible, and the efficiency is quite high!
(0) 讚! | gren

作者: 水月傲玉


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2022-03-17 08:54:33 評論於
I'll give it a try
(0) 讚! | 水月傲玉

作者: 努力啊大雅珍


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2022-01-04 14:23:06 評論於
Do you have the official website link for this magazine? It's not working right now
(0) 讚! | 努力啊大雅珍

作者: 维尔娜菲茨杰拉德


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-12-30 23:33:29 評論於
ORCID is the Researcher and Contributor ID, an open and non-profit organization. ORCID ID is a unique and persistent academic identity for contributors, allowing authors to be distinguished from other researchers, and recording all their relevant research activities.

Researchers can register for their ORCID ID for free at https://orcid.org/signin by providing their name, email, and setting a password
(0) 讚! | 维尔娜菲茨杰拉德

作者: 陶宜三岁啦


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-12-26 12:30:50 評論於
What is ORCID ID? How to register?
(0) 讚! | 陶宜三岁啦

作者: 南风乙酉


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-09-08 15:13:26 評論於
Please translate the following paragraph into English and Japanese, and use ":" and ":" as headings
(0) 讚! | 南风乙酉

作者: 巴蜀友翠


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-08-20 21:08:58 評論於
Review Speed: 1.0 | Submission Acceptance Rate: 75.0
Experience Sharing: Does this journal accept articles on bioinformatics?
(0) 讚! | 巴蜀友翠

作者: 凌霄高洁


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2017-07-16 18:08:56 評論於
Stuck in a standstill, but being at this critical point, it is not easy to push forward anymore. With a score of over 4 points, it can be considered satisfactory
(0) 讚! | 凌霄高洁

作者: 奕剑甜雅


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2017-02-13 19:17:42 評論於
Review speed: 1.0 | Submission acceptance rate: 50.0 Experience sharing: The score is relatively stable, and the review process is quite efficient. Recommended
(0) 讚! | 奕剑甜雅

作者: 凌霄高洁


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2013-04-24 20:30:54 評論於
I don't know what wangjs is talking about. This sentence is everywhere. It must be cherished, but how do we cherish it? It's like we already have it. Is subscribing to these magazines like a joke?
(0) 讚! | 凌霄高洁

作者: 凌霄高洁


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2011-06-29 19:47:01 評論於
Will it drop to 3 points next year? If it drops below 3 points, it won't be worth it
(0) 讚! | 凌霄高洁

作者: 凌霄高洁


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2011-06-29 08:15:17 評論於
Will it drop again next year? What if it falls?
(0) 讚! | 凌霄高洁

首頁    上一頁    1    下一頁    末頁  (頁
/1)

開始撰寫 [IMMUNOLOGY AND CELL BIOLOGY] 的評論:





Contact us

Contact us  

Your name*

Your email*

Your message*

Please fill in all fields and provide a valid email.

Security Code*